In the first known DSS-induced colitis mice study using gene therapy, CD11b+/Gr1+ monocytes were used as the cell vehicle as well as the macrophage-specific promoter (Mac1) to deliver and upregulate CYP27B1 expression in the colon to treat colitis [31]. Here, CYP27B1 is linked to colitis.